CSX Corp: Form 10-Q for the period ended Sep 26, 2014
Filed with the SEC on Oct 15, 2014 and accepted by EDGAR at Oct 15, 2014, 19:25 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-09-26. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2014-06-28 to 2014-09-26 | $3.22bn | us-gaap:SalesRevenueNet |
| Revenue | 9 months2013-12-28 to 2014-09-26 | $9.48bn | us-gaap:SalesRevenueNet |
| Operating income | 3 months2014-06-28 to 2014-09-26 | $976.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2013-12-28 to 2014-09-26 | $2.71bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2014-06-28 to 2014-09-26 | $137.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2013-12-28 to 2014-09-26 | $412.0m | us-gaap:InterestExpense |
| Income tax | 3 months2014-06-28 to 2014-09-26 | $304.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2013-12-28 to 2014-09-26 | $833.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2014-06-28 to 2014-09-26 | $509.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2013-12-28 to 2014-09-26 | $1.44bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2014-06-28 to 2014-09-26 | $0.51 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2013-12-28 to 2014-09-26 | $1.43 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2014-06-28 to 2014-09-26 | $0.51 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2013-12-28 to 2014-09-26 | $1.43 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2014-06-28 to 2014-09-26 | 999,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2013-12-28 to 2014-09-26 | 1,004,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2013-12-28 to 2014-09-26 | $2.30bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2013-12-28 to 2014-09-26 | $1.56bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2013-12-28 to 2014-09-26 | $470.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months2014-06-28 to 2014-09-26 | $131.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Share repurchases | 9 months2013-12-28 to 2014-09-26 | $388.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2014-09-26 | $479.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2014-09-26 | $2.68bn | us-gaap:AssetsCurrent |
| Total assets | At period end2014-09-26 | $32.62bn | us-gaap:Assets |
| Current liabilities | At period end2014-09-26 | $2.23bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2014-09-26 | $21.48bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2014-09-26 | $11.14bn | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |
| Shares outstanding | At period end2014-09-26 | 995,397,303 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000277948-14-000038. Last ingested by Listed: Nov 4, 2026, 17:13 ET. Listed shows no prices and gives no investment advice.